Biologics for Severe Asthma

Targeted Biologic Therapies for Severe Asthma: Opportunities and Implications for Managed Care

Learn from the experts about the latest clinical guidelines and current and emerging targeted biologic therapies for severe asthma, as well as strategies to improve patient-centered care, by joining our interactive live webinar and reading the companion ClinicalThought commentary. Share the downloadable webinar slides with your colleagues.

Suzanne G. Bollmeier, PharmD, FCCP, BCPS, AE-C

Geoffrey C. Wall, PharmD, FCCP, BCPS

ClinicalThought

Using the Guidelines to Make the Best Therapy Decisions for Patients With Severe Asthma

View ClinicalThought

Here’s how I use the guidelines to select an appropriate therapy—such as SMART therapy or targeted biologics—for patients with severe asthma.

Geoffrey C. Wall, PharmD, FCCP, BCPS Released: June 7, 2022

Downloadable Slideset

Slideset

Targeted Biologic Therapies for Severe Asthma: Opportunities and Implications for Managed Care

View Slideset

Gain expert insights on the utilization of targeted biologic therapies in the management of severe asthma, to improve clinical and economic outcomes.

Suzanne G. Bollmeier, PharmD, FCCP, BCPS, AE-C

Geoffrey C. Wall, PharmD, FCCP, BCPS Released: May 17, 2022

Targeted Biologic Therapies for Severe Asthma: Opportunities and Implications for Managed Care

ClinicalThought

Using the Guidelines to Make the Best Therapy Decisions for Patients With Severe Asthma

Downloadable Slideset

Targeted Biologic Therapies for Severe Asthma: Opportunities and Implications for Managed Care

Leaving the CCO site